✦ LIBER ✦

Optimal primary treatment of patients with an HER2 overexpressing tumour

✍ Scribed by M.J Piccart; G Demonty; L Dal Lago; S Dolci; C Straehle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab treatment in patients with a

✍ Alessandro D. Santin; Stefania Bellone; Juan J. Roman; Jesse K. McKenney; Sergio 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Weekly Gemcitabine and Trastuzumab in th

✍ Denise A. Yardley; Howard A. Burris III; Sarah Hanson; F. Anthony Greco; David R 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Trastuzumab in combination with cisplati

✍ Zinner, Ralph G; Glisson, Bonnie S; Fossella, Frank V; Pisters, Katherine M.W; K 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB

370 Primary treatment with weekly doceta

✍ J. Bines; A. Murad; S. Lago; B. Ferrari; J. Andrade; E. Abdo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Advances in the Adjuvant Treatment of HE

✍ Chris Schwab; Joyce A. O'Shaughnessy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 467 KB

5061 POSTER Impact of Systemic Anti-Her2

✍ Bartsch, R.; Berghoff, A.; Pluschnig, U.; Bago-Horvath, Z.; Dubsky, P.; Rottenfu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB